Latest Research & Publications
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
![Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies](https://www.ohe.org/wp-content/uploads/2023/01/Cancer_WellcomeCollection_landscape.jpg)
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
![It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?](https://www.ohe.org/wp-content/uploads/2022/02/Towse-Fenwick-post-review-final-v2-01.png)
Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
![Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations](https://www.ohe.org/wp-content/uploads/2023/01/Healthcare-systems_AdobeStock_Rawpixel.com_landscape.jpg)